Stress-Related Blood Biomarkers

  • Agnieszka J. SzczepekEmail author
  • Birgit Mazurek


In the previous chapters, we presented and discussed the hormonal mechanisms of emotional stress, we also introduced stress-related psychological disorders frequently occurring in tinnitus patients, and we revealed how the daily rhythms—when disrupted by stress—could contribute to auditory pathologies such as tinnitus. Here, we want to bring the reader up to date on the topic of stress-related blood biomarkers and their possible use in the diagnostics and monitoring of tinnitus.


Tinnitus Stress Biomarkers 



AJ Szczepek thankfully acknowledges the research support of Dürr Foundation, the German Tinnitus Foundation and Sonnenfeld Foundation. B. Mazurek acknowledges the support of Dürr Foundation.


  1. Aggarwal BB, Moffat B, Harkins RN (1984) Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. J Biol Chem 259:686–691PubMedGoogle Scholar
  2. Attias J, Reshef I, Shemesh Z, Salomon G (2002) Support for the central theory of tinnitus generation: a military epidemiological study. Int J Audiol 41:301–307CrossRefPubMedGoogle Scholar
  3. Baltrusch HJ, Andres J, Stangel W (1990) Psychosocial stress, personality and blood platelet behavior: implications for psychophysiologic and psychoneuroimmunologic research. Int J Neurosci 51:237–239CrossRefPubMedGoogle Scholar
  4. Berkiten G, Yildirim G, Topaloglu I, Ugras H (2013) Vitamin B12 levels in patients with tinnitus and effectiveness of vitamin B12 treatment on hearing threshold and tinnitus. B-ENT 9:111–116PubMedGoogle Scholar
  5. Bower JE, Ganz PA, Aziz N (2005) Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 67:277–280CrossRefPubMedGoogle Scholar
  6. Bruggemann P, Szczepek AJ, Rose M, McKenna L, Olze H, Mazurek B (2016) Impact of multiple factors on the degree of tinnitus distress. Front Hum Neurosci 10:341CrossRefPubMedPubMedCentralGoogle Scholar
  7. Brydon L, Edwards S, Jia H, Mohamed-Ali V, Zachary I, Martin JF, Steptoe A (2005) Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain Behav Immun 19:540–546CrossRefPubMedGoogle Scholar
  8. Brydon L, Magid K, Steptoe A (2006) Platelets, coronary heart disease, and stress. Brain Behav Immun 20:113–119CrossRefPubMedGoogle Scholar
  9. Buske-Kirschbaum A, von Auer K, Krieger S, Weis S, Rauh W, Hellhammer D (2003) Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease? Psychosom Med 65:806–810CrossRefPubMedGoogle Scholar
  10. Buske-Kirschbaum A, Ebrecht M, Hellhammer DH (2010) Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun 24:1347–1353CrossRefPubMedGoogle Scholar
  11. Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA (2016) The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry 6:e958CrossRefPubMedPubMedCentralGoogle Scholar
  12. Chacon-Fernandez P, Sauberli K, Colzani M, Moreau T, Ghevaert C, Barde YA (2016) Brain-derived neurotrophic factor in megakaryocytes. J Biol Chem 291:9872–9881CrossRefPubMedPubMedCentralGoogle Scholar
  13. Chen YC, Feng Y, JJ X, Mao CN, Xia W, Ren J, Yin X (2016) Disrupted brain functional network architecture in chronic tinnitus patients. Front Aging Neurosci 8:174PubMedPubMedCentralGoogle Scholar
  14. da Mota LM, dos Santos Neto LL, de Carvalho JF (2009) Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity? Clin Rheumatol 28:1127–1134CrossRefPubMedGoogle Scholar
  15. Dallos P (2008) Cochlear amplification, outer hair cells and prestin. Curr Opin Neurobiol 18:370–376CrossRefPubMedPubMedCentralGoogle Scholar
  16. Deniz M, Bayazit YA, Celenk F, Karabulut H, Yilmaz A, Gunduz B, Saridogan C, Dagli M, Erdal E, Menevse A (2010) Significance of serotonin transporter gene polymorphism in tinnitus. Otol Neurotol 31:19–24CrossRefPubMedGoogle Scholar
  17. DeVon HA, Piano MR, Rosenfeld AG, Hoppensteadt DA (2014) The association of pain with protein inflammatory biomarkers: a review of the literature. Nurs Res 63:51–62CrossRefPubMedGoogle Scholar
  18. Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8:1314–1325PubMedGoogle Scholar
  19. Dinarello CA (1999) Cytokines as endogenous pyrogens. J Infect Dis 179(Suppl 2):S294–S304CrossRefPubMedGoogle Scholar
  20. Figueiredo RR, Azevedo AA, Penido NO (2016) Positive association between tinnitus and arterial hypertension. Front Neurol 7:171CrossRefPubMedPubMedCentralGoogle Scholar
  21. Finch CE (2012) Evolution of the human lifespan, past, present, and future: phases in the evolution of human life expectancy in relation to the inflammatory load. Proc Am Philos Soc 156:9–44PubMedGoogle Scholar
  22. Finlay CM, Walsh KP, Mills KH (2014) Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev 259:206–230CrossRefPubMedGoogle Scholar
  23. Gallegos AM, Lytle MC, Moynihan JA, Talbot NL (2015) Mindfulness-based stress reduction to enhance psychological functioning and improve inflammatory biomarkers in trauma-exposed women: a pilot study. Psychol Trauma 7:525–532CrossRefPubMedPubMedCentralGoogle Scholar
  24. Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J, Ceglarek U (2016) Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair. J Chromatogr A 1464:64–71CrossRefPubMedGoogle Scholar
  25. Gogcegoz Gul I, Eryilmaz G, Ozten E, Hizli Sayar G (2014) Decreased mean platelet volume in panic disorder. Neuropsychiatr Dis Treat 10:1665–1669PubMedPubMedCentralGoogle Scholar
  26. Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, Groettrup M, Elbert T, Kolassa IT (2013) Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 13:40CrossRefPubMedPubMedCentralGoogle Scholar
  27. Goto F, Saruta J, Kanzaki S, To M, Tsutsumi T, Tsukinoki K, Ogawa K (2012) Various levels of plasma brain-derived neurotrophic factor in patients with tinnitus. Neurosci Lett 510:73–77CrossRefPubMedGoogle Scholar
  28. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83–87CrossRefPubMedGoogle Scholar
  29. Hall DA, Haider H, Szczepek AJ, Lau P, Rabau S, Jones-Diette J, Londero A, Edvall NK, Cederroth CR, Mielczarek M, Fuller T, Batuecas-Caletrio A, Brueggemen P, Thompson DM, Norena A, Cima RF, Mehta RL, Mazurek B (2016) Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults. Trials 17:270CrossRefPubMedPubMedCentralGoogle Scholar
  30. Hebert S, Lupien SJ (2007) The sound of stress: blunted cortisol reactivity to psychosocial stress in tinnitus sufferers. Neurosci Lett 411:138–142CrossRefPubMedGoogle Scholar
  31. Hernandez ME, Mendieta D, Perez-Tapia M, Bojalil R, Estrada-Garcia I, Estrada-Parra S, Pavon L (2013) Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder. Clin Dev Immunol 2013:267871CrossRefPubMedPubMedCentralGoogle Scholar
  32. Hirano T (1998) Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16:249–284CrossRefPubMedGoogle Scholar
  33. Hirano T (2014) Revisiting the 1986 molecular cloning of interleukin 6. Front Immunol 5:456CrossRefPubMedPubMedCentralGoogle Scholar
  34. Ho LJ, Luo SF, Lai JH (2015) Biological effects of interleukin-6: clinical applications in autoimmune diseases and cancers. Biochem Pharmacol 97:16–26CrossRefPubMedGoogle Scholar
  35. Hodes GE, Menard C, Russo SJ (2016) Integrating interleukin-6 into depression diagnosis and treatment. Neurobiol Stress 4:15–22CrossRefPubMedPubMedCentralGoogle Scholar
  36. Hughes D (2007) Biomarkers in medicine: responding to the needs of an emerging community. Biomark Med 1:1–1CrossRefPubMedGoogle Scholar
  37. Jern C, Wadenvik H, Mark H, Hallgren J, Jern S (1989) Haematological changes during acute mental stress. Br J Haematol 71:153–156CrossRefPubMedGoogle Scholar
  38. Kalliolias GD, Ivashkiv LB (2016) TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol 12:49–62CrossRefPubMedGoogle Scholar
  39. Kemal O, Muderris T, Basar F, Kutlar G, Gul F (2016) Prognostic value of mean platelet volume on tinnitus. J Laryngol Otol 130:162–165CrossRefPubMedGoogle Scholar
  40. Kim DK, Chung DY, Bae SC, Park KH, Yeo SW, Park SN (2014) Diagnostic value and clinical significance of stress hormones in patients with tinnitus. Eur Arch Otorhinolaryngol 271:2915–2921CrossRefPubMedGoogle Scholar
  41. Kirschbaum C, Pirke KM, Hellhammer DH (1993) The ‘trier social stress test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76–81CrossRefPubMedGoogle Scholar
  42. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999) Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 61:154–162CrossRefPubMedGoogle Scholar
  43. Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M (2011) In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35:744–759CrossRefGoogle Scholar
  44. Kyle RA (1995) Prognostic factors in multiple myeloma. Stem Cells 13(Suppl 2):56–63PubMedGoogle Scholar
  45. Lopez-Escamez JA, Bibas T, Cima RF, Van de Heyning P, Knipper M, Mazurek B, Szczepek AJ, Cederroth CR (2016) Genetics of tinnitus: an emerging area for molecular diagnosis and drug development. Front Neurosci 10:377CrossRefPubMedPubMedCentralGoogle Scholar
  46. Marchi A, Vellucci R, Mameli S, Rita Piredda A, Finco G (2009) Pain biomarkers. Clin Drug Investig 29(Suppl 1):41–46CrossRefPubMedGoogle Scholar
  47. Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerstrom T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA (2009) Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of amp-activated protein kinase. Diabetologia 52:1409–1418CrossRefPubMedGoogle Scholar
  48. Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22–34CrossRefPubMedPubMedCentralGoogle Scholar
  49. Murray CL, Obiang P, Bannerman D, Cunningham C (2013) Endogenous il-1 in cognitive function and anxiety: a study in il-1ri-/- mice. PLoS One 8:e78385CrossRefPubMedPubMedCentralGoogle Scholar
  50. Nowell PC (2007) Discovery of the philadelphia chromosome: a personal perspective. J Clin Invest 117:2033–2035CrossRefPubMedPubMedCentralGoogle Scholar
  51. Parham K (2015) Prestin as a biochemical marker for early detection of acquired sensorineural hearing loss. Med Hypotheses 85:130–133CrossRefPubMedGoogle Scholar
  52. Parham K, Dyhrfjeld-Johnsen J (2016) Outer hair cell molecular protein, prestin, as a serum biomarker for hearing loss: proof of concept. Otol Neurotol 37:1217–1222CrossRefPubMedGoogle Scholar
  53. Petrowski K, Wintermann GB, Schaarschmidt M, Bornstein SR, Kirschbaum C (2013) Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Int J Psychophysiol 88:35–39CrossRefPubMedGoogle Scholar
  54. Potter WZ (2015) Biomarkers of brain structure and function for neurodegenerative disorders: are they adequate for go/no go decisions in drug development? Clin Pharmacol Ther 98:472–474CrossRefPubMedGoogle Scholar
  55. Ramanathan S, Ajit SK (2016) Microrna-based biomarkers in pain. Adv Pharmacol 75:35–62CrossRefPubMedGoogle Scholar
  56. Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, van der Meer JW (2017) Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation 14:16CrossRefPubMedPubMedCentralGoogle Scholar
  57. Sanchez-Villegas A, Doreste J, Schlatter J, Pla J, Bes-Rastrollo M, Martinez-Gonzalez MA (2009) Association between folate, vitamin b(6) and vitamin b(12) intake and depression in the sun cohort study. J Hum Nutr Diet 22:122–133CrossRefPubMedGoogle Scholar
  58. Sarikaya Y, Bayraktar C, Karatas M, Dogan S, Olt S, Kaskalan E, Turkbeyler IH (2016a) Increased mean platelet volume in patients with idiopathic subjective tinnitus. Eur Arch Otorhinolaryngol 273:3533–3536CrossRefPubMedGoogle Scholar
  59. Sarikaya Y, Bayraktar C, Karatas M, Dogan S, Olt S, Kaskalan E, Turkbeyler IH (2016b) Reply to the letter to the editor by beyan concerning: increased mean platelet volume in patients with idiopathic subjective tinnitus. Eur Arch Otorhinolaryngol 273:4037–4038CrossRefPubMedGoogle Scholar
  60. Savastano M, Aita M, Barlani F (2007) Psychological, neural, endocrine, and immune study of stress in tinnitus patients: any correlation between psychometric and biochemical measures? Ann Otol Rhinol Laryngol 116:100–106CrossRefPubMedGoogle Scholar
  61. Schlee W, Pryss RC, Probst T, Schobel J, Bachmeier A, Reichert M, Langguth B (2016) Measuring the moment-to-moment variability of tinnitus: the trackyourtinnitus smart phone app. Front Aging Neurosci 8:294CrossRefPubMedPubMedCentralGoogle Scholar
  62. Schmitt K, Holsboer-Trachsler E, Eckert A (2016) BDNF in sleep, insomnia, and sleep deprivation. Ann Med 48:42–51CrossRefPubMedGoogle Scholar
  63. Shemesh Z, Attias J, Ornan M, Shapira N, Shahar A (1993) Vitamin B12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss. Am J Otolaryngol 14:94–99CrossRefPubMedGoogle Scholar
  64. Simeon D, Knutelska M, Yehuda R, Putnam F, Schmeidler J, Smith LM (2007) Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry 61:966–973CrossRefPubMedGoogle Scholar
  65. Simoens VL, Hebert S (2012) Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge. BMC Ear Nose Throat Disord 12:4CrossRefPubMedPubMedCentralGoogle Scholar
  66. Singh C, Kawatra R, Gupta J, Awasthi V, Dungana H (2016) Therapeutic role of vitamin B12 in patients of chronic tinnitus: a pilot study. Noise Health 18:93–97CrossRefPubMedPubMedCentralGoogle Scholar
  67. Stein J, Paulke A, Schacher B, Noehte M (2014) An extraordinary form of the melkersson-rosenthal syndrome successfully treated with the tumour necrosis factor-alpha blocker adalimumab. BMJ Case Rep 2014:bcr2014204674CrossRefPubMedPubMedCentralGoogle Scholar
  68. Szczepek AJ, Haupt H, Klapp BF, Olze H, Mazurek B (2014) Biological correlates of tinnitus-related distress: an exploratory study. Hear Res 318:23–30CrossRefPubMedGoogle Scholar
  69. Tyano S, Zalsman G, Ofek H, Blum I, Apter A, Wolovik L, Sher L, Sommerfeld E, Harell D, Weizman A (2006) Plasma serotonin levels and suicidal behavior in adolescents. Eur Neuropsychopharmacol 16:49–57CrossRefPubMedGoogle Scholar
  70. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Trakada G, Chrousos GP (2005) Il-6 and its circadian secretion in humans. Neuroimmunomodulation 12:131–140CrossRefPubMedGoogle Scholar
  71. Villada C, Hidalgo V, Almela M, Salvador A (2016) Individual differences in the psychobiological response to psychosocial stress (trier social stress test): the relevance of trait anxiety and coping styles. Stress Health 32:90–99CrossRefPubMedGoogle Scholar
  72. Weber C, Arck P, Mazurek B, Klapp BF (2002) Impact of a relaxation training on psychometric and immunologic parameters in tinnitus sufferers. J Psychosom Res 52:29–33CrossRefPubMedGoogle Scholar
  73. WHO (1993) Environmental health criteria: biomarkers and risk assessment: concepts and principles. In: WHO (ed) International programme on chemical safety, vol 155. WHO, GenevaGoogle Scholar
  74. Wohleb ES, Patterson JM, Sharma V, Quan N, Godbout JP, Sheridan JF (2014) Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior. J Neurosci 34:2583–2591CrossRefPubMedPubMedCentralGoogle Scholar
  75. Xiong H, Yang H, Liang M, Ou Y, Huang X, Cai Y, Lai L, Pang J, Zheng Y (2016) Plasma brain-derived neurotrophic factor levels are increased in patients with tinnitus and correlated with therapeutic effects. Neurosci Lett 622:15–18CrossRefPubMedGoogle Scholar
  76. Xu J, Ye Y, Zhang H, Szmitkowski M, Makinen MJ, Li P, Xia D, Yang J, Wu Y, Wu H (2016) Diagnostic and prognostic value of serum interleukin-6 in colorectal cancer. Medicine (Baltimore) 95:e2502CrossRefGoogle Scholar
  77. Yuksel F, Karatas D (2016) Can platelet indices be new biomarkers for subjective tinnitus? J Craniofac Surg 27:e420–e424CrossRefPubMedGoogle Scholar
  78. Zirke N, Seydel C, Arsoy D, Klapp BF, Haupt H, Szczepek AJ, Olze H, Goebel G, Mazurek B (2013a) Analysis of mental disorders in tinnitus patients performed with composite international diagnostic interview. Qual Life Res 22:2095–2104CrossRefPubMedGoogle Scholar
  79. Zirke N, Seydel C, Szczepek AJ, Olze H, Haupt H, Mazurek B (2013b) Psychological comorbidity in patients with chronic tinnitus: analysis and comparison with chronic pain, asthma or atopic dermatitis patients. Qual Life Res 22:263–272CrossRefPubMedGoogle Scholar
  80. Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311–322CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology, Head and Neck SurgeryCharité University HospitalBerlinGermany
  2. 2.Tinnitus Center, Charité University HospitalBerlinGermany

Personalised recommendations